Physicians

The resource is intended for primary care providers who care for individuals and populations who may be at risk for infection with M. tuberculosis. The guide includes latent TB infection diagnosis and treatment information, sample documentation forms, and additional resources.

This material summarizes the U.S. recommendations for latent TB infection testing and treatment. The document includes information on who should be tested for TB infection, recommended treatment regimens for latent TB infection, and more.

This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released in 2020.

This guide provides information for understanding a program’s epidemiology, determining if and when an outbreak might be occurring, and when additional resources and activities might be needed.

This monograph describes 10 steps in the diagnosis, management, and prevention of Syphilis.

The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events. The medication tracker includes space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 12-dose regimen.

Speakers for this webinar include the Deputy Director of the Global TB Institute and a survivor of MDR-TB. By the end of the webinar, participants will be able to: define stigma in the context of tuberculosis prevention and care, describe how stigma affects persons with tuberculosis, and apply interventions in the health care setting and community to reduce stigma.

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

This video presents information on the difference between TB infection and disease, testing methods and recommendations, and interpretation of test results. The video also discusses special considerations for testing and the medical evaluation process.

The video contains information on the basics of TB infection, targeted testing, recommendations for screening and testing high-risk groups, and patient education messages.